Aims: Transcatheter aortic valve implantation (TAVI) is an emerging alternative to medical
therapy reserved to a limited population with severe aortic stenosis. Quality-of-life (QoL) is a …

Aims: Comorbidities pose a major challenge to screening, selection and follow-up of
transcatheter aortic valve implantation (TAVI) patients as well as to the procedure itself. The …

BACKGROUND: This prospective study was designed to evaluate the hemodynamic results
of transcatheter aortic valve implantation (TAVI) with the CoreValve prosthesis (Medtronic …

Objective To evaluate short-and long-term changes in quality of life (QoL) in patients
undergoing transcatheter aortic valve implantation (TAVI) and to assess differences in …

Objectives: The goal of this study was to assess serial changes in patient health-related
quality of life (HRQOL) over time and identify predictors of patient benefit. Background …

Background: In aortic stenosis, valvulo-arterial impedance (Zva) estimates the overall left
ventricular afterload (valve and arterial component). We investigated the association of Zva …

Background. Transcatheter aortic valve implantation (TAVI) is currently recommended for
patients with severe aortic stenosis at intermediate or high surgical risk. The decision …

Older adults with progressively worsening aortic valve stenosis are limited in their treatment
options. Conventional treatment replaces the aortic valve via open-heart surgery …

BACKGROUND: The conventional surgical aortic bioprostheses used for treatment of aortic
stenosis (AS) are inherently stenotic in nature. The more favorable mechanical profile of the …

Objective To assess late outcome after transcatheter aortic valve implantation (TAVI) up to 6
years and to analyse its predictive factors with a particular emphasis on functional status …